The GoTaq Probe 1-Step RT-qPCR System from Fitchburg-based Promega Corp. is now in a Centers for Disease Control and Prevention COVID-19 diagnostic protocol for emergency use, according to a company announcement.
The FDA amended the CDC’s diagnostic COVID-19 test to acknowledge that the Promega master mix is an approved amplification reagent for laboratories using the CDC’s assay. The assay protocol is used by hundreds of public health labs and clinical testing labs in the United States.
